1. Home
  2. GIC vs MESO Comparison

GIC vs MESO Comparison

Compare GIC & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GIC
  • MESO
  • Stock Information
  • Founded
  • GIC 1949
  • MESO 2004
  • Country
  • GIC United States
  • MESO Australia
  • Employees
  • GIC N/A
  • MESO N/A
  • Industry
  • GIC Industrial Machinery/Components
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GIC Industrials
  • MESO Health Care
  • Exchange
  • GIC Nasdaq
  • MESO Nasdaq
  • Market Cap
  • GIC 1.1B
  • MESO 1.2B
  • IPO Year
  • GIC 1995
  • MESO N/A
  • Fundamental
  • Price
  • GIC $25.34
  • MESO $14.63
  • Analyst Decision
  • GIC
  • MESO Strong Buy
  • Analyst Count
  • GIC 0
  • MESO 4
  • Target Price
  • GIC N/A
  • MESO $13.50
  • AVG Volume (30 Days)
  • GIC 101.4K
  • MESO 552.8K
  • Earning Date
  • GIC 10-29-2024
  • MESO 08-28-2024
  • Dividend Yield
  • GIC 3.97%
  • MESO N/A
  • EPS Growth
  • GIC N/A
  • MESO N/A
  • EPS
  • GIC 1.71
  • MESO N/A
  • Revenue
  • GIC $1,333,700,000.00
  • MESO $5,902,000.00
  • Revenue This Year
  • GIC $4.92
  • MESO $66.05
  • Revenue Next Year
  • GIC $3.66
  • MESO $348.27
  • P/E Ratio
  • GIC $14.82
  • MESO N/A
  • Revenue Growth
  • GIC 9.80
  • MESO N/A
  • 52 Week Low
  • GIC $25.01
  • MESO $1.61
  • 52 Week High
  • GIC $46.97
  • MESO $19.15
  • Technical
  • Relative Strength Index (RSI)
  • GIC 25.02
  • MESO 64.37
  • Support Level
  • GIC $25.11
  • MESO $12.20
  • Resistance Level
  • GIC $28.07
  • MESO $19.15
  • Average True Range (ATR)
  • GIC 0.66
  • MESO 0.98
  • MACD
  • GIC -0.16
  • MESO 0.37
  • Stochastic Oscillator
  • GIC 7.43
  • MESO 48.93

About GIC Global Industrial Company

Global Industrial Co is a value-added industrial distributor. It distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: